Petra Kollárová-Brázdová

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Eduard Jirkovský, Anna Jirkovská, Hana Bavlovič Piskáčková et al. · Circulation Heart Failure · 2021 · 58 citations · Full text

Medicine, Cardiology, Pharmacology +17

Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity

Petra Kollárová-Brázdová, Anna Jirkovská, Galina Karabanovich et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 20 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

The electromembrane extraction of pharmaceutical compounds from animal tissues

Hana Bavlovič Piskáčková, Petra Kollárová-Brázdová, Radim Kučera et al. · Analytica Chimica Acta · 2021 · 16 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +7

Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model<i>in vivo</i>

Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Galina Karabanovich et al. · Clinical Science · 2021 · 12 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection

Jan Kubeš, Galina Karabanovich, Anh Cong et al. · Nature Communications · 2025 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15